InflaRx NV (IFRX)
2.15
+0.09
(+4.37%)
USD |
NASDAQ |
Nov 22, 12:46
InflaRx Shareholders Equity (Quarterly): 72.91M for Sept. 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
September 30, 2024 | 72.91M |
June 30, 2024 | 88.06M |
March 31, 2024 | 102.33M |
December 31, 2023 | 113.39M |
September 30, 2023 | 124.89M |
June 30, 2023 | 135.46M |
March 31, 2023 | 85.69M |
December 31, 2022 | 94.75M |
September 30, 2022 | 97.74M |
June 30, 2022 | 106.69M |
March 31, 2022 | 106.16M |
December 31, 2021 | 119.20M |
September 30, 2021 | 133.65M |
June 30, 2021 | 147.10M |
March 31, 2021 | 162.77M |
December 31, 2020 | 95.77M |
Date | Value |
---|---|
September 30, 2020 | 105.31M |
June 30, 2020 | 102.48M |
March 31, 2020 | 111.98M |
December 31, 2019 | 120.02M |
September 30, 2019 | 134.74M |
June 30, 2019 | 148.80M |
March 31, 2019 | 163.92M |
December 31, 2018 | 173.18M |
September 30, 2018 | 184.25M |
June 30, 2018 | 187.05M |
March 31, 2018 | 138.13M |
December 31, 2017 | 143.28M |
September 30, 2017 | -42.59M |
June 30, 2017 | -37.38M |
December 31, 2016 | -27.16M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
72.91M
Minimum
Sep 2024
162.77M
Maximum
Mar 2021
111.32M
Average
106.43M
Median
Shareholders Equity (Quarterly) Benchmarks
Affimed NV | 19.21M |
BioNTech SE | 21.35B |
Immatics NV | 427.24M |
CureVac NV | 809.41M |
ATAI Life Sciences NV | 145.72M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 89.00M |
Total Liabilities (Quarterly) | 16.09M |
Current Ratio | 5.308 |